Certolizumab pegol – new option in the treatment of psoriatic arthritis
It has been proven that tumor necrosis factor (TNF) plays an important role in the pathophysiology of psoriatic arthritis (PsA). TNF inhibitors have been demonstrated to improve the skin and joint manifestations of psoriasis. New possibilities of treatment of the disease have appeared due to availab...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Termedia Publishing House
2014-07-01
|
| Edice: | Rheumatology |
| Témata: | |
| On-line přístup: | http://www.termedia.pl/Certolizumab-pegol-new-option-in-the-treatment-of-psoriatic-arthritis,18,23171,1,1.html |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|